These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36309416)

  • 1. Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism.
    Galbiati FF; Goldman AL; Gattu A; Guzelce EC; Bhasin S
    Urol Clin North Am; 2022 Nov; 49(4):593-602. PubMed ID: 36309416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone.
    Rodrigues Dos Santos M; Bhasin S
    Annu Rev Med; 2021 Jan; 72():75-91. PubMed ID: 33217248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone supplementation therapy for older men: potential benefits and risks.
    Gruenewald DA; Matsumoto AM
    J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
    J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M; Lipshultz LI
    Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male Reproduction and Aging.
    Figueiredo MG; Gagliano-Jucá T; Basaria S
    Endocrinol Metab Clin North Am; 2023 Jun; 52(2):211-228. PubMed ID: 36948776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen replacement in men with hypogonadism and erectile dysfunction.
    Albrecht-Betancourt M; Hijazi RA; Cunningham GR
    Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone Therapy: What We Have Learned From Trials.
    Corona G; Torres LO; Maggi M
    J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of testosterone therapy in older men.
    Spitzer M; Huang G; Basaria S; Travison TG; Bhasin S
    Nat Rev Endocrinol; 2013 Jul; 9(7):414-24. PubMed ID: 23591366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
    Borst SE; Yarrow JF
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and risks of testosterone therapy in older men.
    Cardona Attard C; Fava S
    Minerva Urol Nefrol; 2019 Jun; 71(3):217-229. PubMed ID: 30700083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
    Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
    J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone treatment of late-onset hypogonadism - benefits and risks.
    Snyder P
    Rev Endocr Metab Disord; 2022 Dec; 23(6):1151-1157. PubMed ID: 35266057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale.
    Basaria S
    Endocr Pract; 2013; 19(5):853-63. PubMed ID: 24014017
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.